Amphastar Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Amphastar Pharmaceuticals,

10/05/2023 24:47

* Amphastar Pharmaceuticals Inc  AMPH.OQ  reported quarterly
adjusted earnings of 62 cents​​ per share for the quarter ended
in March. The mean expectation of five analysts for the quarter
was for earnings of 48 cents per share.
    * Revenue rose 16.3% to $140.02 million from a year ago;
analysts
expected $134.16 million. 
    * The mean earnings estimate of analysts had risen by
about 14.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Amphastar Pharmaceuticals Inc shares had fallen by 2.9%
this
quarter and gained 30.0% so far this year.
    * Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $41.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 11:47 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.48           0.62           Beat
 Dec. 31 2022      0.41           0.73           Beat
 Sep. 30 2022      0.39           0.38           Missed
 Jun. 30 2022      0.35           0.39           Beat